Extend PIX301: A phase III randomized trial of pixantrone versus other chemotherapeutic agents as third-line monotherapy in patients with relapsed, aggressive non-Hodgkin's lymphoma

Andreas Engert, Rauol Herbrecht, Armando Santoro, Pier Luigi Zinzani, Igor Gorbatchevsky

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)152-154
Number of pages3
JournalClinical Lymphoma and Myeloma
Issue number2
Publication statusPublished - Sep 2006


  • Anthracyclines
  • Cardiac toxicity
  • Single-agent therapy

ASJC Scopus subject areas

  • Cancer Research
  • Oncology
  • Hematology

Cite this